Koyfin Home > Directory > Health Care > Aimmune Therap > Cash and Short-Term Investments

Aimmune Therap Cash and Short-Term Investments Chart (AIMT)

Aimmune Therap annual/quarterly Cash and Short-Term Investments from 2014 to 2020.
  • Aimmune Therap Cash and Short-Term Investments for the quarter ending June 06, 2020 was $314m a 37.74% increase of 118m year over year
  • Aimmune Therap Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $314m a 37.74% increase of 118m year over year
  • Aimmune Therap Annual Cash and Short-Term Investments for 2019 was $144m a -111.78% decrease of -160m from 2018
  • Aimmune Therap Annual Cash and Short-Term Investments for 2018 was $304m a 39.98% increase of 122m from 2017
  • Aimmune Therap Annual Cash and Short-Term Investments for 2017 was $182m a -36.45% decrease of -67m from 2016
Other Balance Sheet Metrics:
  • Aimmune Therap Total Assets for the quarter ending September 09, 2018 was $287m a 28.01% increase of 81m year over year
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Equity for the quarter ending September 09, 2018 was $247m a 28.06% increase of 69m year over year
View Chart On Koyfin

Quarterly AIMT Cash and Short-Term Investments Data

06/2020$314m
03/2020$358m
12/2019$144m
09/2019$195m
06/2019$244m
03/2019$283m
12/2018$304m
09/2018$255m
06/2018$290m
03/2018$322m

Annual AIMT Cash and Short-Term Investments Data

2019$144m
2018$304m
2017$182m
2016$249m
2015$192m
2014$2m
2013$12m